Spectral Ai - Class A (MDAI) closed at $1.54 on November 10, 2026, up 0.7% from the previous close, on volume of 79,272 shares (30-day average 129,858).
Data as of November 10, 2026.
Spectral AI GAAP EPS of -$0.11 beats by $0.03, revenue of $2.86M misses by $2.47M
Seeking Alpha News (Tue, 10-Nov 4:40 PM ET)
Spectral AI Announces 2026 Third Quarter Financial Results
Globe Newswire (Tue, 10-Nov 4:15 PM ET)
Spectral AI Schedules 2026 Third Quarter Financial Results and Conference Call
Globe Newswire (Wed, 28-Oct 8:30 AM ET)
Globe Newswire (Tue, 13-Oct 8:30 AM ET)
Spectral AI Submits New Technology Add-On Payment (NTAP) Application for DeepView System
Globe Newswire (Tue, 6-Oct 8:30 AM ET)
Globe Newswire (Thu, 1-Oct 8:30 AM ET)
Globe Newswire (Thu, 24-Sep 4:15 PM ET)
Globe Newswire (Wed, 16-Sep 4:15 PM ET)
Spectral AI to Present at H.C. Wainwright 28th Annual Global Investment Conference
Globe Newswire (Tue, 1-Sep 8:30 AM ET)
Spectral AI Announces 2026 Second Quarter Financial Results
Globe Newswire (Tue, 11-Aug 4:05 PM ET)
Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.
Spectral Ai - Class A trades on the NASDAQ stock market under the symbol MDAI.
As of November 10, 2026, MDAI stock price climbed to $1.54 with 79,272 million shares trading.
MDAI has a beta of 1.62, meaning it tends to be more sensitive to market movements. MDAI has a correlation of 0.10 to the broad based SPY ETF.
MDAI has a market cap of $49.56 million. This is considered a Sub-Micro Cap stock.
Last quarter Spectral Ai - Class A reported $4 million in Revenue and -$.13 earnings per share. This fell short of revenue expectation by $-644,400 and exceeded earnings estimates by $.01.
In the last 3 years, MDAI traded as high as $3.72 and as low as $.82.
The top ETF exchange traded funds that MDAI belongs to (by Net Assets): VTI, VXF, IWC.
MDAI has underperformed the market in the last year with a return of -20.6%, while the SPY ETF gained +12.9%. In the last 3 month period, MDAI fell short of the market, returning -12.0%, while SPY returned -2.8%. However, in the most recent 2 weeks MDAI has outperformed the stock market by returning +2.7%, while SPY returned -2.0%.
MDAI support price is $1.47 and resistance is $1.59 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MDAI shares will trade within this expected range on the day.
